Chloroprocaine Hydrochloride Patent Expiration
Chloroprocaine Hydrochloride is Used for regional anesthesia through intrathecal administration. It was first introduced by Fresenius Kabi Usa Llc
Chloroprocaine Hydrochloride Patents
Given below is the list of patents protecting Chloroprocaine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Iheezo | US11969403 | Topical formulations of chloroprocaine and methods of using same | May 14, 2039 | Harrow Eye |
| Iheezo | US10792271 | Topical formulations of chloroprocaine and methods of using same | Sep 15, 2038 | Harrow Eye |
| Clorotekal | US9504666 | Chloroprocaine-based pharmaceutical composition for repeated intrathecal administration | Dec 11, 2033 | B Braun Medical |
| Clorotekal | US8969412 | Use for a composition comprising chloroprocaine HCL, a new composition comprising chloroprocaine HCL and a method for its manufacture | Sep 05, 2026 | B Braun Medical |
Chloroprocaine Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Chloroprocaine Hydrochloride Generic API Manufacturers
Several generic applications have been filed for Chloroprocaine Hydrochloride. The first generic version for Chloroprocaine Hydrochloride was by Hospira Inc and was approved on Apr 16, 1982. And the latest generic version is by Hikma Pharmaceuticals Usa Inc and was approved on Sep 9, 1998.
Given below is the list of companies who have filed for Chloroprocaine Hydrochloride generic, along with the locations of their manufacturing plants worldwide.
1. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Chloroprocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Hikma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2% | injectable | Prescription | INJECTION | AP | Sep 9, 1998 |
| 3% | injectable | Prescription | INJECTION | AP | Sep 9, 1998 |
Manufacturing Plant Locations New
Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||
| Portugal |
| |||||||||
| Jordan |
| |||||||||
2. HOSPIRA
Hospira Inc has filed for 2 different strengths of generic version for Chloroprocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Hospira.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 3% | injectable | Discontinued | INJECTION | N/A | Apr 16, 1982 |
| 2% | injectable | Discontinued | INJECTION | N/A | Apr 16, 1982 |
Manufacturing Plant Locations New
Hospira's manufacturing plants are situated in 3 countries - Australia, United States, Dominican Republic (the). Given below are the details of these plant locations as well as the firm names of Hospira as present at those locations.
| Country | City | Firm Name | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Australia |
| |||||||||||||
| United States |
| |||||||||||||
| Dominican Republic (the) |
| |||||||||||||